| 1. |
- Rahbi, R., et al.
(författare)
-
Neutralisation of group vi donors by hydrogen in gallium arsenide
- 1994
-
Ingår i: Solid State Communications. - : Elsevier BV. - 0038-1098 .- 1879-2766. ; 91:3, s. 187-190
-
Tidskriftsartikel (refereegranskat)abstract
- The infrared absorption of GaAs:S and GaAs:Te samples partially neutralised by hydrogen show two local modes with very similar frequencies. These modes are comparable to the ones already reported in GaAs:Se. These results are interpreted by assuming that neutralisation takes place by the formation of a bond between a Ga atom first neighbour of the chalcogen and a H atom in an antibonding location. This assumption is strengthened by ab initio calculations that provide also frequencies of the right order of magnitude.
|
|
| 2. |
|
|
| 3. |
- Jones, R, et al.
(författare)
-
Identification of the dominant nitrogen defect in silicon
- 1994
-
Ingår i: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 72:12, s. 1882-1885
-
Tidskriftsartikel (refereegranskat)abstract
- The structure of the dominant N pair defect in Si is determined from channeling, infrared local vibrational mode spectroscopy, and ab initio local density functional theory. Channeling experiments show that the N atoms are displaced by 1.1±0.1 Å from lattice sites along 〈100〉. Annealing experiments reveal that this N site is associated with two N-related local vibrational modes originating from the N pair. The ab initio calculations demonstrate that the pair consists of two neighboring 〈100〉 oriented N-Si split interstitials, arranged in an antiparallel configuration, and with four N-Si bonds forming a square lying on {011}.
|
|
| 4. |
|
|
| 5. |
- Nielsen, B. Bech, et al.
(författare)
-
Observation and theory of the H2* defect in silicon
- 1994
-
Ingår i: Proceedings of the 17th International Conference on Defects in Semiconductors. - : Trans Tech Publications Inc.. ; , s. 845-852
-
Konferensbidrag (refereegranskat)
|
|
| 6. |
|
|
| 7. |
- Tiensuu Janson, Eva, et al.
(författare)
-
[111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours : the predictive value for somatostatin analogue treatment
- 1994
-
Ingår i: European Journal of Endocrinology. - : Oxford University Press (OUP). - 0804-4643 .- 1479-683X. ; 131:6, s. 577-581
-
Tidskriftsartikel (refereegranskat)abstract
- This study was performed to evaluate whether the presence or absence of somatostatin receptors in malignant carcinoid tumours detected by [111In-DTPA-D-Phe1]octreotide scintigraphy can be used to predict response to somatostatin analogue treatment. Thirty patients were investigated, 28 with midgut carcinoid tumours and two with foregut carcinoid tumours. Twenty-seven patients showed pathological uptake in tumour lesions at scintigraphy; of these, 22 responded to somatostatin analogue treatment using octreotide, somatuline or octastatin, while five patients failed to respond. None of the three patients displaying negative scintigraphic investigations responded to treatment with somatostatin analogues. These results show a good correlation between the somatostatin receptor status and the patients' ability to respond to somatostatin analogue treatment (p = 0.014). We conclude that somatostatin receptor scintigraphy using [111In-DTPA-D-Phe1]octreotide can be used to select patients with malignant carcinoid tumours suitable for somatostatin analogue treatment and exclude those that will not benefit from such medication.
|
|
| 8. |
- Weber, G, et al.
(författare)
-
The phospholipase C b 3 gene located in the MEN 1 region shows loss of expression in endocrine tumors
- 1994
-
Ingår i: Human Molecular Genetics. - : Oxford University Press (OUP). - 0964-6906 .- 1460-2083. ; 3:10, s. 1775-1781
-
Tidskriftsartikel (refereegranskat)abstract
- Oncogenesis of tumours related to multiple endocrine neoplasia type 1 (MEN1) is associated with somatic deletions involving the MEN1 locus, suggesting inactivation of a tumour suppressor gene in this region. Identification of meiotic cross-overs in MEN1 families has placed the MEN1 locus centromeric of D11S807. An extended deletion mapping was performed in 27 primary parathyroid tumours, and identified D11S427 as the closest centromeric flanking marker. Through physical mapping using newly isolated cDNA clones, we estimated the distance between the flanking markers D11S807 and D11S427 to be less than 900 kb. One of these cDNA clones showed expression of a 4.4 kb message in multiple tissues, including those affected in MEN1, while in five endocrine tumours no transcript was detected. Sequence characterization showed that this gene encodes for the phospholipase C beta 3, a key enzyme in signal transduction.
|
|
